Streetbeat News

Assets

UNH

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 10 years by 11.05% on an annualized basis, producing an average annual return of 21.26%. If an investor had bought $100 of UNH stock 10 years ago, it would be worth $696.50 today.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

ABBV

Over the past 10 years, AbbVie (NYSE:ABBV) has outperformed the market by 2.69% on an annualized basis, producing an average annual return of 12.89%. If an investor had bought $100 of ABBV stock 10 years ago, it would be worth $335.41 today.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 2:00 pm

BCHUSD

BTCUSD

ETHUSD

Bitcoin and Ethereum traded higher, with Bitcoin surpassing the $30,000 mark and Ethereum trading above $1,800. Aptos was the top gainer in the last 24 hours, while XDC Network was the biggest loser. The global crypto market cap rose to $1.19 trillion, a 24-hour gain of 1.4%.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 1:49 pm

GM

GM's CFO Paul Jacobson has announced that the company has sent manufacturing resources to its battery module tooling supplier to increase production. GM built over 1,000 Cadillac Lyriqs in July, with production rates rising. However, the company has been unable to meet the high demand for its electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:48 pm

EXR

HST

VNQ

XLRE

The real estate sector is experiencing a shake-up as 30-year mortgage rates reach 7.09%, the highest since 2002. This surge is attributed to the unveiling of the Treasury's funding plan and a downgrade in the U.S. government debt rating. Mortgage applications have declined by 3.1%, marking the third consecutive decline. This has put pressure on real estate stocks, with the Real Estate Select Sector SPDR Fund (XLRE) and the Vanguard Real Estate ETF (VNQ) experiencing drops of 4.7% and 4% respectively. Host Hotels & Resorts, Inc. (HST) and Extra Space Storage, Inc. (EXR) have seen significant declines of 9% and 6% respectively.

Portfolio Pulse from Piero Cingari

August 09, 2023 | 1:37 pm

BLK

BTCUSD

Billionaire David Rubenstein, co-founder of The Carlyle Group, expressed his confidence in Bitcoin's endurance due to the global interest it attracts. He also pointed out that major financial firms like BlackRock and Fidelity are seeking approval to launch Bitcoin ETFs. Other companies such as Valkyrie, WisdomTree, VanEck, Ark Invest, and Invesco are also applying for a Bitcoin ETF.

Portfolio Pulse from Murtuza Merchant

August 09, 2023 | 1:24 pm

SBLK

Star Bulk Carriers' President, Hamish Norton, discussed the company's Q2 2023 financial results, business strategy, and outlook for the dry bulk market in a recent podcast. He highlighted fleet renewal, upgrades for fuel efficiency and emission compliance, carbon capture, and capital allocation. He also discussed the supply and demand side of the dry bulk outlook and shipowners investing in dry bulk shipping.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:20 pm

CBT

Cabot Corporation (NYSE:CBT) has joined the U.S. Department of Energy's (DOE's) Better Plants program, a voluntary partnership aimed at improving energy efficiency across the U.S. industrial sector. Cabot expects the partnership to help advance its energy efficiency performance and support its goal of achieving net zero emissions by 2050. All of Cabot's U.S.-based manufacturing sites are part of the program. The company has recently exceeded its 2025 global sustainability goal of exporting 200% of the energy it imports.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 1:16 pm

QTRX

Quanterix Corporation (NASDAQ:QTRX) has announced the appointment of Vandana Sriram as its new Chief Financial Officer (CFO), effective from August 21, 2023. Sriram, who has over 20 years of experience in financial strategy and transformation, will replace Michael Doyle. Doyle will transition to the role of Executive Director, Finance, focusing on strategic growth programs until his retirement in March 2024.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:39 pm

JAGX

Napo Pharmaceuticals, a subsidiary of Jaguar Health (NASDAQ:JAGX), has submitted a Stage 1 funding application to the Biomedical Advanced Research and Development Authority (BARDA) for the development of NP-300, a drug candidate for the treatment of moderate-to-severe diarrhea, including cholera. The company aims to increase American preparedness and response time in the event of exposure to cholera due to bioterrorism or global warming. Napo's Investigational New Drug (IND) application for NP-300 was activated by the FDA in September 2022.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:36 pm